Gilead Sciences
GILD
1,560 hedge funds and large institutions have $140B invested in Gilead Sciences in 2015 Q2 according to their latest regulatory filings, with 152 funds opening new positions, 640 increasing their positions, 606 reducing their positions, and 71 closing their positions.
114% more first-time investments, than exits
New positions opened: 152 | Existing positions closed: 71
53% more funds holding in top 10
Funds holding in top 10: 180 → 275 (+95)
16% more capital invested
Capital invested by funds: $121B → $140B (+$19B)
4% more funds holding
Funds holding: 1,493 → 1,560 (+67)
6% more repeat investments, than reductions
Existing positions increased: 640 | Existing positions reduced: 606
40% less call options, than puts
Call options by funds: $2.23B | Put options by funds: $3.7B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$774M |
| 2 |
D.E. Shaw & Co
New York
|
+$410M |
| 3 |
ECU
Egerton Capital (UK)
London,
United Kingdom
|
+$351M |
| 4 |
EIP
Epoch Investment Partners
New York
|
+$308M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
+$270M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$1.06B |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$602M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$392M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$386M |
| 5 |
State Street
Boston,
Massachusetts
|
-$345M |
GILD Hedge Fund Activity: Q2 2015 in Review
1,560 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in Gilead Sciences (GILD) for Q2 2015, worth a combined $140B — up 16% from $121B a quarter earlier.
Buyers outnumbered sellers: 152 funds opened new GILD positions and 71 closed out — a net gain of 81 holders — while 640 added to existing stakes and 606 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $774M. The largest seller was Goldman Sachs, cutting an estimated $1.06B.
- 1,560 institutional investors held Gilead Sciences (GILD) as of Q2 2015, up from 1,493 in Q1 2015.
- Funds reported $140B of Gilead Sciences stock for Q2 2015, up 16% quarter-over-quarter.
- 152 funds opened new Gilead Sciences positions in Q2 2015 and 71 closed out, a net change of +81 holders.
- The largest Gilead Sciences buyer in Q2 2015 was JP Morgan Chase, an estimated $774M added.
- The largest Gilead Sciences seller in Q2 2015 was Goldman Sachs, an estimated $1.06B sold.
Based on aggregated 13F filings for Q2 2015.